Skip to main content
Premium Trial:

Request an Annual Quote

German Hospital Integrates New Bio.logis PGx Suite Into Clinical Workflow

NEW YORK (GenomeWeb) – A German hospital is the first to integrate the Bio.logis Genetic Information Management Suite into a clinical genomics program, the company said today.

The Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology at Robert Bosch Hospital in Stuttgart is linking the new Bio.logis GIM platform into its information systems, including a genotyping platform and a web portal for patients to view their own pharmacogenomic data. Once the integration is complete in a few months, the Bio.logis suite will be able to send recommendations from a pharmacogenomic test directly to the ordering physician and to the patient, Frankfurt, Germany-based Bio.logis said.

"Straightforward therapy instructions can put treating physicians in a position to better categorize and reduce the risk of adverse side effects and therapy discontinuation," Institute for Clinical Pharmacology Director Matthias Schwab said in a statement. The web portal also will give patients easy access to their pharmacogenomic information for future treatments, whether at Bosch or another facility anywhere in the world, he added.  

"The pharmacogenetic diagnostics concept now launched at [Robert Bosch Hospital] embodies the idea of personalized medicine with a comprehensive end-to-end solution for individual patients," said Bio.logis GIM Managing Director Enrico Just.

Bio.logis is a spinout of the Bio.logis Center for Human Genetics in Frankfurt.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.